On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...